2Fraimow HS,Abrutyn E.Pathogens resistant to antimicrobial agents[].Infectious Disease Clinics of North America.1995
3Jones RN.The current and future impact of antimicrobial resistance among nosocomial bacterial pathogents[].Diagn Microbiol Infect Dis.
4Nikaido H,Liu W,Rosenberg EY.Outer membrane permeability and beta-lactamase stability of dipolar ionic cephalosporins containing methoxyimino substituents[].Antimicrobial Agents and Chemotherapy.1990
5Sanders CC.New beta-lactams: New problems for the internist[].Annals of Internal Medicine.1991
6Fung-Tome J,Huczko E,Pearce M,et al.Frequency of in vitro resistance of Pseudomonas aeruginosa to cefepime, ceftazidime and cefotaxime[].Antimicrobial Agents and Chemotherapy.1988
7Goldberg DM.The cephalosporins[].The Medical Clinics of North America.1987
8Pucci MJ,Boice-Sowek J,Kessler RE,et al.Comparison of cephpime, cefpirome, and cefaclidine binding affinities for penicillin-binding proteins in Escherichia coli K-12 and Pseudomonas aeruginosa SC 8329[].Antimicrobial Agents and Chemotherapy.1991
9Cornaglia G,Russell K,Satta G,et al.Relative importance of outer membrane permeability and group 1 beta-lactamas as determinants of mecropenem and imipenem activitis against Enterobacter cloacae[].Antimicrobial Agents and Chemotherapy.1995
10Gustaferro CA,Steckelberg JM.Cephalosporins antimicrobial agents and related compounds[].Mayo Clinic Proceedings.1991
